reports
Intesa Sanpaolo S.p.A.: 1 director
A director at Intesa Sanpaolo S.p.A. sold 10,000 shares at 3.453EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
- Carole Braudeau
- Carole Braudeau
- Benoit Valleaux
- Steven Gould
Intesa Sanpaolo : Q1 2024 provides a little more validation of the gro...
>Outperform rating confirmed – target price lifted to € 4.2 (vs € 4.0) - Q1 2024 results underpin our Outperform recommendation, with a reassuring trend on the key operating points (NII momentum, control of costs and moderate CoR), and ultimately on capital/shareholder returns. The group reiterated its guidance on 2024 (net profit > € 8bn in 2024 and 2025 vs € 7.7bn in 2023) notably thanks to its highly diversified business model (revenues linked to long-term savings)...
- Benoit Valleaux
- Steven Gould
Intesa Sanpaolo : Le T1 2024 valide un peu plus les solides fondamenta...
>Opinion Surperformance confortée – OC porté à 4.2 € (vs 4.0 €) - Le T1 2024 vient conforter notre opinion Surperformance avec une évolution rassurante sur les points clés opérationnels (momentum NII, maîtrise des coûts & niveau modéré de CdR), et in fine sur le capital/retour à l’actionnaire. Le groupe réitère ses guidances pour 2024 (RN > 8 Md€ en 2024 & 2025 vs 7.7 Md€ en 2023), ce que nous validons grâce au business model très diversifié (revenus liés à l’épargne ...
- Benoit Valleaux
- Bruno Cavalier
- Steven Gould
INFINEON INFINEON TECHNOLOGIES AG
LR LEGRAND SA
AMS AMS AG
RCO REMY COINTREAU SA
DEMANT DEMANT A/S
GLE SOCIETE GENERALE S.A. CLASS A
ELG ELMOS SEMICONDUCTOR SE
TPE PVA TEPLA AG
ISP INTESA SANPAOLO S.P.A.
SOI SOITEC SA
ASM ASM INTERNATIONAL N.V.
SIX2 SIXT SE
AIXA AIXTRON SE
PFV PFEIFFER VACUUM TECHNOLOGY AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
WAF SILTRONIC AG
MELE MELEXIS NV
SMHN SUESS MICROTEC AG
VACN VAT GROUP AG
XFAB X-FAB SILICON FOUNDRIES SE
ASML ASML HOLDING NV
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
ALKAL KALRAY SA
JEN JENOPTIK AG
IHG INTERCONTINENTAL HOTELS GROUP PLC
DTG DAIMLER TRUCK
ARM ARM HOLDINGS PLC
- Benoit Valleaux
- Bruno Cavalier
- Steven Gould
INFINEON INFINEON TECHNOLOGIES AG
LR LEGRAND SA
AMS AMS AG
RCO REMY COINTREAU SA
DEMANT DEMANT A/S
GLE SOCIETE GENERALE S.A. CLASS A
ELG ELMOS SEMICONDUCTOR SE
TPE PVA TEPLA AG
ISP INTESA SANPAOLO S.P.A.
SOI SOITEC SA
ASM ASM INTERNATIONAL N.V.
SIX2 SIXT SE
AIXA AIXTRON SE
PFV PFEIFFER VACUUM TECHNOLOGY AG
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
WAF SILTRONIC AG
MELE MELEXIS NV
SMHN SUESS MICROTEC AG
VACN VAT GROUP AG
XFAB X-FAB SILICON FOUNDRIES SE
ASML ASML HOLDING NV
STM STMICROELECTRONICS NV
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
ALKAL KALRAY SA
JEN JENOPTIK AG
IHG INTERCONTINENTAL HOTELS GROUP PLC
DTG DAIMLER TRUCK
ARM ARM HOLDINGS PLC
AIR LIQUIDE : DROITS DE VOTE
PARIS--(BUSINESS WIRE)-- Regulatory News: Air Liquide (Paris:AI): Déclaration au 30 Avril 2024 du mois de: Nombre d’actions composant le capital Nombre théorique des droits de vote (y compris actions auto-détenues) Nombre réel de droits de vote (déduction faite des actions auto-détenues) Avril 524 166 853 524 166 853 522 508 315 Déclaration précédente Mars 2024 Mars 524 769 659 524 769 659 522 499 871 Air Liquide est un leader mondial des gaz, technologies et services pour l’industrie et la s...
- Javier Esteban
INTESA SANPAOLO: RDOS. 1T’24 (ANÁLISIS BANCO SABADELL)
Rdos. 1T'24 vs 1T'23: M. Intereses: 3.932 M euros (+20,8% vs +19,9% BS(e) y +20,5% consenso); M. Bruto: 6.732 M euros (+11,1% vs +8,4% BS(e) y +9,2% consenso); M. Neto: 4.162 M euros (+18,2% vs +9,8% BS(e) y +11,8% consenso); BDI: 2.301 M euros (+17,6% vs +13,4% BS(e) y n/a consenso). Rdos. 1T'24 vs 4T'23: M. Intereses: 3.932 M euros (-1,6% vs -2,4% BS(e) y -1,9% consenso); M. Bruto: 6.732 M euros (+5,6% vs +3,0% BS(e) y +3,8% consenso); M. Neto: 4.162 M euros (+43,3% vs +33,1% BS(e) y +35,6% co...
- Carole Braudeau
- Carole Braudeau
- Jerôme Bodin
LR LEGRAND SA
FRA FRAPORT AG
LI KLEPIERRE SA
ALV ALLIANZ SE
ORSTED ORSTED
RAA RATIONAL AG
INGA ING GROEP NV
SAN BANCO SANTANDER S.A.
IHG INTERCONTINENTAL HOTELS GROUP PLC
MRNA MODERNA INC.
VWS VESTAS WIND SYSTEMS
UMG UNIVERSAL MUSIC GROUP NV
DSY DASSAULT SYSTEMES SA
DTG DAIMLER TRUCK
LIN LINDE PUBLIC LIMITED COMPANY
SHUR SHURGARD SELF STORAGE LIMITED
- Bruno Cavalier
- Jerôme Bodin
LR LEGRAND SA
FRA FRAPORT AG
LI KLEPIERRE SA
ALV ALLIANZ SE
ORSTED ORSTED
RAA RATIONAL AG
INGA ING GROEP NV
SAN BANCO SANTANDER S.A.
IHG INTERCONTINENTAL HOTELS GROUP PLC
MRNA MODERNA INC.
VWS VESTAS WIND SYSTEMS
UMG UNIVERSAL MUSIC GROUP NV
DSY DASSAULT SYSTEMES SA
DTG DAIMLER TRUCK
LIN LINDE PUBLIC LIMITED COMPANY
SHUR SHURGARD SELF STORAGE LIMITED
- Dominic Rose
- Naresh Chouhan
Sanofi - The Path to €120 (BUY, TP EUR120 [110], 7pgs)
This new analysis shows how Sanofi shares get to €120 (+c.30%) by end 2025. We have conducted a foundational analysis that investors can refer to over the next 18mths as Sanofi releases at least 15 P2 & P3 pipeline readouts. We show the upside potential from every single readout and show that just 4 drugs could add €18/share upon successful readouts. In addition to multiple readouts, the likely Consumer Health spin in Q4, the tolebrutinib overhang being resolved one way or another and a strong C...
- Maria Paz Ojeda
AXA: VENTAS 1T’24 (ANÁLISIS BANCO SABADELL)
Ventas 1T'24 vs 1T'23: Ingresos total grupo: 33.972 M euros (+6,8% vs +4,7% BS(e) y +6,1% consenso); No Vida: 19.754 M euros (+6,5% vs +4,7% BS(e) y +5,5% consenso); Vida: 9.014 M euros (+7,4% vs +4,2% BS(e) y +7,4% consenso); Salud: 9.014 M euros (+9,5% vs +6,0% BS(e) y +6,2% consenso); Gestión de activos: 385 M euros (2,7% vs 3,2% BS(e) y 0,0% de consenso).
- Benoit Valleaux
- Roland Pfaender
- MBA
- CFA
- CCRA
AXA : Significant price increases in P&C personal lines
>Group revenues up 6% l-f-l in Q1 - AXA reported its Q1 activity indicators after trading yesterday evening and will hold its investor conference this morning. Total group revenues came in at € 33.972bn (+6.8% reported, +6% l-f-l), slightly below our forecast (€ 34.345bn), but just ahead of the consensus (€ 33.776bn). In P&C, revenues amounted to € 19.8bn (+7% l-f-l), with growth for both commercial lines (+7% l-f-l) and personal lines (+6% l-f-l), as well as an in...
- Research Department
INFORME DIARIO 03 MAYO + RDOS. ESPAÑA Y EUROPA 1T’24. IDEAS DESTACADAS...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACERINOX, IBERDROLA. EUROPA: AXA, LINDE, SOCIÉTE GÉNÉRALE. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 1T’24 que se publicarán en España y Europa en los próximos días. Dudas en el mercado a pesar de una Fed complaciente A excepción del Ibex y FTSE 100, jornada en rojo en las principales bolsas europeas c...
- Benoit Valleaux
- Steven Gould
Santander : A robust start to 2024 and guidance confirmed
>Outperform rating maintained - Target price raised to € 5.5 (vs € 5.4) - Santander’s Q1 2024 results underpin our Outperform rating and lead us to increase our net profit estimates (+2% on average over the period 2024-2026e), due to a slightly more favourable stance on the top line trend. Our target price has thus been lifted to € 5.5 (vs € 5.4). The trend in the group’s operating performances remains broadly solid with the validation of the main financial targets se...
- Benoit Valleaux
- Steven Gould
Santander : Début d’année 2024 solide & guidances confirmées
>Opinion Surperformance maintenue – OC porté à 5.5 € (vs 5.4 €) - Les résultats T1 2024 de Santander viennent conforter notre opinion Surperformance et nous amènent à rehausser nos estimations de RN (+2% en moyenne sur la période 2024-26), en raison d’un biais un peu plus favorable notamment sur l’évolution de la topline. Notre OC est en conséquence porté à 5.5 € (vs 5.4 €). L’évolution des performances opérationnelles du groupe reste globalement solides avec une vali...
- Benoit Valleaux
- Roland Pfaender
- MBA
- CFA
- CCRA
AXA : Fortes augmentations tarifaires en assurance dommages de particu...
>Les revenus du groupe sont en hausse de 6% en comparable au T1 - AXA a publié hier soir après Bourse ses indicateurs d’activité du T1 et tiendra ce matin sa conférence téléphonique investisseurs. Les revenus totaux du groupe se sont élevés à 33 972 M€ (+6.8% en publié, +6% à données comparables), légèrement inférieurs à notre attente (34 345 M€), mais légèrement supérieurs au consensus (33 776 M€). En assurance dommages, les revenus ont été de 19.8 Md€ (+7% à donnée...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.